GCP Conference-2012

The Good Clinical Practice (GCP) concept has been introduced to ensure a quality product is released in the market, particularly when it concerns food products and medicines.

Los Angeles, CA (prHWY.com) November 19, 2012 - The Good Clinical Practice (GCP) concept has been introduced to ensure a quality product is released in the market, particularly when it concerns food products and medicines. Manufacturing processes are clearly defined and controlled.

A standard GCP process involves certain procedures to address loopholes. The major steps include receiving complaints about marketed drugs that are examined, the causes of quality defects getting investigated, and appropriate measures being taken.

All critical manufacturing processes are validated to ensure consistency and compliance with specifications. The required form of control is applied to the manufacturing processes as part of the practice. Proper validation measures are adopted for each process change taking place, as it influences the quality of a drug.

Records are made, manually or by instruments, during manufacture that show whether all the steps required by the defined procedures and instructions are taken into account. The distribution of the drugs is carried out by minimizing the risk and the channel representatives are trained on underlying good manufacturing practices documentation procedures.

FDA regulations provide for recalling of drugs that violate GCP norms and are considered hazardous for consumption, and directives are issued to manufacturers to avoid such defects in future.

###

Tag Words: clinical conference

Categories: Health

Press Release Contact
1-650-268-9744

Link To This Press Release:

URL HTML Code